# VOYAGERS Health-Tech Fund

> VOYAGERS Health-Tech Fund is a VC fund backing Health Care and Biotechnology. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 7
- Last investment: Nov 2022
- Lead investor: 0%
- Last updated: Aug 2026
- Website: https://voyagers.io/fund/

VOYAGERS Health-Tech Fund is a VC fund focused on Health Care and Biotechnology. VOYAGERS Health-Tech Fund invests in early-stage companies in health-tech and life sciences

## Contacts

5 contacts available for VOYAGERS Health-Tech Fund. Shizune tracks 1 team members at VOYAGERS Health-Tech Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/voyagers-health-tech-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 6 | 86% |
| Biotechnology | 2 | 29% |
| Medical | 1 | 14% |
| Big Data | 1 | 14% |
| Hospital | 1 | 14% |

17 industries tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 5 | 71% |
| India | 1 | 14% |
| United States | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| David Rowan | Founder & Investment Manager | 25 | https://shizune.co/investors/profile/david-rowan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Five Lives | SharpTx is a London-based Digital Therapeutics SME developing “Sharp”, a direct-to-consumer brain health mobile app to help everyone measure and reduce their risk of cognitive decline through an improved lifestyle. | $3.8M | Seed | Nov 15, 2022 |  |
| Vinehealth | Vinehealth’s technology applies behavioural science and AI to deliver highly personalised patient support at scale; thereby generating rich patient-reported data to inform health service delivery, drug development and research. | $5.5M | Seed | Dec 03, 2021 |  |
| VIVAN Therapeutics | VIVAN Therapeutics, a company pioneering personalized cancer therapeutics using a new assay technology. MPT licensed technology from the Center for Personalized Cancer Therapeutics at Mt Sinai New York and is launching the world’s most comprehensive, personal genomics-based, block-chain enabled drug screening service. All recommended treatmentcombinations will include a cancer drug and a non cancer drug, making treatments less toxic and more affordable. Intelligently designed personalized treatment. Revolutionary cancer care. | $3.7M | Seed | Sep 01, 2021 |  |
| Hey Jane | Hey Jane is a telehealth startup that connects patients to healthcare providers that offer online medical consultations. The company's innovative Complete Care model utilizes technology for unparalleled layers of support: medical, emotional, and social. Since 2021, Hey Jane has helped nearly 20,000 patients get the care they need. And this isonly the beginning; soon, we will reimagine care for even more common but underserved treatments, with the ultimate goal of becoming the most trusted healthcare company out there—one that pushes the boundaries of access with convenient, inclusive, and patient-driven care. | $3.6M | Seed | Jul 29, 2021 |  |
| CyGenica | CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics. | $1.4M | Seed | Jun 08, 2021 |  |
| Vidya Health | Vidya Health is the medical technology company based in London |  | Seed | Sep 01, 2020 |  |
| Lifted | They only accept the best Carers. If they wouldn't them to look after their loved ones then they don't make the cut. They equip them with innovative technology so they can focus on delivering amazing care.Lifted provides exceptional care for loved ones, and peace of mind for families. We take an innovative and personalised approach toimproving the home care experience. With a big heart and industry leading technology we do home care differently; better quality Carers, exceptional reliability with 24/7 support, and a care platform that keeps you informed. All at a fair price. | $2M | Seed | Jul 02, 2020 |  |

7 of 7 investments shown.

## Co-investors
- [Headline](https://shizune.co/investors/profile/headlinevc) — VC Fund, 2 deals together
- [37 Angels](https://shizune.co/investors/profile/37-angels) — VC Fund, 1 deal together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Ascension](https://shizune.co/investors/profile/ascension-ventures-limited) — VC Fund, 1 deal together
- [Avonmore Developments](https://shizune.co/investors/profile/avonmore-developments) — VC Fund, 1 deal together
- [Flybridge](https://shizune.co/investors/profile/flybridge-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does VOYAGERS Health-Tech Fund invest in?

VOYAGERS Health-Tech Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact VOYAGERS Health-Tech Fund?

Public channels for VOYAGERS Health-Tech Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at VOYAGERS Health-Tech Fund?

The team at VOYAGERS Health-Tech Fund includes David Rowan (Founder & Investment Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co